These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21368585)

  • 1. Recent advances of cowpea mosaic virus-based particle technology.
    Montague NP; Thuenemann EC; Saxena P; Saunders K; Lenzi P; Lomonossoff GP
    Hum Vaccin; 2011 Mar; 7(3):383-90. PubMed ID: 21368585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic engineering and characterization of Cowpea mosaic virus empty virus-like particles.
    Sainsbury F; Saxena P; Aljabali AA; Saunders K; Evans DJ; Lomonossoff GP
    Methods Mol Biol; 2014; 1108():139-53. PubMed ID: 24243247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for participation of RNA 1-encoded elicitor in Cowpea mosaic virus-mediated concurrent protection.
    Bruening G; Buzayan JM; Ferreiro C; Lim W
    Virology; 2000 Jan; 266(2):299-309. PubMed ID: 10639316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cowpea Mosaic Virus Nanoparticles and Empty Virus-Like Particles Show Distinct but Overlapping Immunostimulatory Properties.
    Wang C; Beiss V; Steinmetz NF
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31375592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The structures of a naturally empty cowpea mosaic virus particle and its genome-containing counterpart by cryo-electron microscopy.
    Hesketh EL; Meshcheriakova Y; Thompson RF; Lomonossoff GP; Ranson NA
    Sci Rep; 2017 Apr; 7(1):539. PubMed ID: 28373698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of cowpea mosaic virus as a potential source of novel vaccines.
    Porta C; Spall VE; Lin T; Johnson JE; Lomonossoff GP
    Intervirology; 1996; 39(1-2):79-84. PubMed ID: 8957673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential of chimaeric plant virus particles as novel, stable vaccines.
    Xu F; Jones TD; Rodgers PB
    Dev Biol Stand; 1996; 87():201-5. PubMed ID: 8854018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Production of hepatitis B virus core particles protein in plants, by using cowpea mosaic virus-based vector].
    Meshcheriakova IuA; El'darov MA; Beales L; Skriabin KG; Lomonossoff GP
    Vopr Virusol; 2008; 53(3):15-20. PubMed ID: 18590129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protoplasts transiently expressing the 200K coding sequence of cowpea mosaic virus B-RNA support replication of M-RNA.
    van Bokhoven H; Verver J; Wellink J; van Kammen A
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2233-41. PubMed ID: 8409945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based engineering of an icosahedral virus for nanomedicine and nanotechnology.
    Steinmetz NF; Lin T; Lomonossoff GP; Johnson JE
    Curr Top Microbiol Immunol; 2009; 327():23-58. PubMed ID: 19198569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cowpea mosaic virus as a vaccine carrier of heterologous antigens.
    Brennan FR; Jones TD; Hamilton WD
    Mol Biotechnol; 2001 Jan; 17(1):15-26. PubMed ID: 11280928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cowpea mosaic virus RNA-1 acts as an amplicon whose effects can be counteracted by a RNA-2-encoded suppressor of silencing.
    Liu L; Grainger J; Cañizares MC; Angell SM; Lomonossoff GP
    Virology; 2004 May; 323(1):37-48. PubMed ID: 15165817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of viral vectors to produce hepatitis B virus core particles in plants.
    Mechtcheriakova IA; Eldarov MA; Nicholson L; Shanks M; Skryabin KG; Lomonossoff GP
    J Virol Methods; 2006 Jan; 131(1):10-5. PubMed ID: 16112207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of Cowpea Mosaic Virus-Binding Peptides.
    Chan SK; Steinmetz NF
    Biomacromolecules; 2021 Aug; 22(8):3613-3623. PubMed ID: 34314166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vivo Fate of Cowpea Mosaic Virus In Situ Vaccine: Biodistribution and Clearance.
    Affonso de Oliveira JF; Chan SK; Omole AO; Agrawal V; Steinmetz NF
    ACS Nano; 2022 Nov; 16(11):18315-18328. PubMed ID: 36264973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-expression of the capsid proteins of Cowpea mosaic virus in insect cells leads to the formation of virus-like particles.
    Shanks M; Lomonossoff GP
    J Gen Virol; 2000 Dec; 81(Pt 12):3093-3097. PubMed ID: 11086140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific Packaging of Custom RNA Molecules into Cowpea Mosaic Virus-like Particles.
    Peyret H; Lomonossoff GP
    Methods Mol Biol; 2022; 2480():103-111. PubMed ID: 35616860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of cowpea mosaic virus-based vectors for the production of vaccines in plants.
    Cañizares MC; Lomonossoff GP; Nicholson L
    Expert Rev Vaccines; 2005 Oct; 4(5):687-97. PubMed ID: 16221070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cowpea mosaic virus: from the presentation of antigenic peptides to the display of active biomaterials.
    Chatterji A; Burns LL; Taylor SS; Lomonossoff GP; Johnson JE; Lin T; Porta C
    Intervirology; 2002; 45(4-6):362-70. PubMed ID: 12602357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based design of peptide presentation on a viral surface: the crystal structure of a plant/animal virus chimera at 2.8 A resolution.
    Lin T; Porta C; Lomonossoff G; Johnson JE
    Fold Des; 1996; 1(3):179-87. PubMed ID: 9079380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.